These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15167601)

  • 1. Classical pathway complement destruction is not responsible for the loss of human erythrocytes during porcine liver perfusion.
    Rees MA; Butler AJ; Negus MC; Davies HF; Friend PJ
    Transplantation; 2004 May; 77(9):1416-23. PubMed ID: 15167601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine livers perfused with human blood mount a graft-versus-"host" reaction.
    Rees MA; Butler AJ; Davies HF; Bolton E; Wight DG; Skepper J; White DJ; Friend PJ
    Transplantation; 2002 May; 73(9):1460-7. PubMed ID: 12023625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test for ability of decay-accelerating factor (DAF, CD55) and CD59 to alleviate complement-mediated damage of xeno-erythrocytes.
    Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Kitamura H; Seya T
    Scand J Immunol; 1993 Jul; 38(1):37-44. PubMed ID: 7687071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-regulatory protein expression and activation of complement cascade on erythrocytes from patients with rheumatoid arthritis (RA).
    Arora M; Kumar A; Das SN; Srivastava LM
    Clin Exp Immunol; 1998 Jan; 111(1):102-6. PubMed ID: 9472668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement.
    Grubbs BC; Benson BA; Dalmasso AP
    Xenotransplantation; 2003 Sep; 10(5):387-97. PubMed ID: 12950982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of injury in porcine livers perfused with blood of patients with fulminant hepatic failure.
    Collins BH; Chari RS; Magee JC; Harland RC; Lindman BJ; Logan JS; Bollinger RR; Meyers WC; Platt JL
    Transplantation; 1994 Dec; 58(11):1162-71. PubMed ID: 7992356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
    Yuan FF; Bryant JA; Fletcher A
    Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
    Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
    Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
    Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
    Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.
    Harris CL; Spiller OB; Morgan BP
    Immunology; 2000 Aug; 100(4):462-70. PubMed ID: 10929073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry and immunoblotting analysis of monoclonal antibodies directed to complement regulatory proteins.
    Blanchard D; Navenot JM; Petit-Le Roux Y; Willem C; Loirat MJ
    Transfus Clin Biol; 1997; 4(1):131-4. PubMed ID: 9095519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of marathon running on expression of the complement regulatory proteins CD55 (DAF) and CD59 (MACIF) on red blood cells.
    Simpson RJ; Florida-James GD; Whyte GP; Middleton N; Shave R; George K; Guy K
    Eur J Appl Physiol; 2007 Jan; 99(2):201-4. PubMed ID: 17089158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor.
    Pascher A; Poehlein C; Storck M; Prestel R; Mueller-Hoecker J; White DJ; Abendroth D; Hammer C
    Transplantation; 1997 Aug; 64(3):384-91. PubMed ID: 9275100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement sensitivity of erythrocytes in a patient with inherited complete deficiency of CD59 or with the Inab phenotype.
    Shichishima T; Saitoh Y; Terasawa T; Noji H; Kai T; Maruyama Y
    Br J Haematol; 1999 Feb; 104(2):303-6. PubMed ID: 10050712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
    Terstappen LW; Nguyen M; Lazarus HM; Medof ME
    J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor.
    Zaltzman AB; Van den Berg CW; Muzykantov VR; Morgan BP
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):651-6. PubMed ID: 7537958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury.
    McCurry KR; Kooyman DL; Alvarado CG; Cotterell AH; Martin MJ; Logan JS; Platt JL
    Nat Med; 1995 May; 1(5):423-7. PubMed ID: 7585088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressed complement activation in human decay accelerating factor transgenic porcine liver cross-circulated with nonhuman primates.
    Matsushita T; Ikai I; Nishitai R; Katsura N; Yamanokuchi S; Matsuo K; Sugimoto S; Shiotani T; Takahashi R; Terajima H; Yamaoka Y
    Transplantation; 2003 Jun; 75(11):1807-12. PubMed ID: 12811238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the xenoantigenicity of neonatal porcine islet-like cell clusters (NPCC) and the efficiency of adenovirus-mediated DAF (CD55) expression.
    Omori T; Nishida T; Komoda H; Fumimoto Y; Ito T; Sawa Y; Gao C; Nakatsu S; Shirakura R; Miyagawa S
    Xenotransplantation; 2006 Sep; 13(5):455-64. PubMed ID: 16925670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAF transgenic pig livers are protected from hyperacute rejection during ex vivo perfusion with human blood.
    Luo Y; Levy G; Ding J; Qi J; Chakbrati S; Garcia BM; Phillips MJ; Kumar N; Friend P; Noble L; Macdonald J; Zhong R; Grant D
    Xenotransplantation; 2002 Jan; 9(1):36-44. PubMed ID: 12005103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.